Diet and psoriasis, part I: Impact of weight loss interventions

Journal of the American Academy of Dermatology

Volumn 71, Issue 1, 2014, Pages 133-140

  Debbaneh, Maya ^a,b   Millsop, Jillian W ^a,c   Bhatia, Bhavnit K ^a,d   Koo, John ^a   Liao, Wilson ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d RUSH MEDICAL COLLEGE   (United States)

Author keywords

body mass index; diet; gastric bypass; nutrition; obesity; psoriasis; weight loss

Indexed keywords

BODY MASS; DIET RESTRICTION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; LOW CALORY DIET; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; REVIEW; STOMACH BYPASS; WEIGHT REDUCTION;

BODY MASS INDEX; DIET; GASTRIC BYPASS; NUTRITION; OBESITY; PSORIASIS; WEIGHT LOSS;

ARTHRITIS, PSORIATIC; BODY MASS INDEX; CALORIC RESTRICTION; COMORBIDITY; GASTRIC BYPASS; HUMANS; OBESITY; PSORIASIS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84903277581     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.02.012     Document Type: Review

References (42)

1. J. Koo Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment Dermatol Clin 14 1996 485 496
2. R.S. Stern Psoriasis Lancet 350 1997 349 353
3. B.B. Davidovici, N. Sattar, J.C. Prinz, P.C. Jörg, L. Puig, and P. Emery et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions J Invest Dermatol 130 2010 1785 1796
4. M. Sumarac-Dumanovic, D. Stevanovic, A. Ljubic, J. Jorga, M. Simic, and D. Stamenkovic-Pejkovic et al. Increased activity of interleukin-23/interleukin- 17 proinflammatory axis in obese women Int J Obes (Lond) 33 2009 151 156
5. J. Choi, and J.Y. Koo Quality of life issues in psoriasis J Am Acad Dermatol 49 Suppl 2003 S57 S61
6. K. Wolk, L. Mallbris, P. Larsson, A. Rosenblad, E. Vingård, and M. Ståhle Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis Acta Derm Venereol 89 2009 492 497
7. S. Kumar, J. Han, T. Li, and A.A. Qureshi Obesity, waist circumference, weight change and the risk of psoriasis in US women J Eur Acad Dermatol Venereol 27 2013 1293 1298
8. M.L. Murray, P.R. Bergstresser, B. Adams-Huet, and J.B. Cohen Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesity Clin Exp Dermatol 34 2009 140 144
9. Y.H. Huang, L.C. Yang, R.Y. Hui, Y.C. Chang, Y.W. Yang, and C.H. Yang et al. Relationships between obesity and the clinical severity of psoriasis in Taiwan J Eur Acad Dermatol Venereol 24 2010 1035 1039
10. V.M. Salvati, T.T. MacDonald, M. Bajaj-Elliott, M. Borrelli, A. Staiano, and S. Auricchio et al. Interleukin 18 and associated markers of T helper cell type 1 activity in celiac disease Gut 50 2002 186 190
11. A.S. Paller, K. Mercy, M.J. Kwasny, S.E. Choon, K.M. Cordoro, and G. Girolomoni Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study JAMA Dermatol 149 2013 166 176
12. E. Edson-Heredia, K.L. Sterling, C.I. Alatorre, G. Cuyun Carter, R. Paczkowski, and V. Zarotsky et al. Heterogeneity of response to biologic treatment: perspective for psoriasis J Invest Dermatol 134 2014 18 23
13. K.A. Papp, R.G. Langley, M. Lebwohl, G.G. Krueger, P. Szapary, and N. Yeilding et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 2) Lancet 371 2008 1675 1684
14. M. Lebwohl, N. Yeilding, P. Szapary, Y. Wang, S. Li, and Y. Zhu et al. Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendations J Am Acad Dermatol 63 2010 571 579
15. A. Menter, K.B. Gordon, C.L. Leonardi, Y. Gu, and O.M. Goldblum Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis J Am Acad Dermatol 63 2010 448 456
16. N. Cassano, A. Galluccio, C. De Simone, F. Loconsole, S.D. Massimino, and A. Plumari et al. Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE data J Biol Regul Homeost Agents 22 2008 233 237
17. L. Naldi, A. Addis, S. Chimenti, A. Giannetti, M. Picardo, and C. Tomino et al. Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis: evidence from the Psocare project Dermatology 217 2008 365 373
18. F. Bardazzi, R. Balestri, E. Baldi, A. Antonucci, S. De Tommaso, and A. Patrizi Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy Dermatol Ther 23 Suppl 2010 S14 S19
19. K. Gordon, N. Korman, E. Frankel, H. Wang, A. Jahreis, and R. Zitnik et al. Efficacy of etanercept in an integrated multistudy database of patients with psoriasis J Am Acad Dermatol 54 Suppl 2006 S101 S111
20. R.J. Driessen, J.B. Boezeman, P.C. van de Kerkhof, and E.M. de Jong Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome Br J Dermatol 160 2009 670 675
21. C. Antoniou, C. Dessinioti, A. Stratigos, G. Avgerinou, P. Stavropoulos, and A. Katsambas Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience J Eur Acad Dermatol Venereol 23 2009 979 982
22. M. Esposito, A. Mazzotta, R. Saraceno, C. Schipani, and S. Chimenti Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasis Int J Immunopathol Pharmacol 22 2009 219 225
23. T.J. Love, Y. Zhu, Y. Zhang, L. Wall-Burns, A. Ogdie, and J.M. Gelfand et al. Obesity and the risk of psoriatic arthritis: a population-based study Ann Rheum Dis 71 2012 1273 1277
24. M.N. Di Minno, R. Peluso, S. Iervolino, R. Lupoli, A. Russolillo, and R. Scarpa et al. Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis Arthritis Care Res 65 2013 141 147
25. H.H. Hermsdorff, M.A. Zulet, I. Abete, and J.A. Martinez Discriminated benefits of a Mediterranean dietary pattern within a hypocaloric diet program on plasma RBP4 concentrations and other inflammatory markers in obese subjects Endocrine 36 2009 445 451
26. P. Jensen, C. Zachariae, R. Christensen, N.R. Geiker, B.K. Schaadt, and S. Stender et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study JAMA Dermatol 149 2013 795 801
27. P. Gisondi, M. Del Giglio, V. Di Francesco, M. Zamboni, and G. Girolomoni Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial Am J Clin Nutr 88 2008 1242 1247
28. I. Rucević, A. Perl, V. Barisić-Drusko, and M. Adam-Perl The role of the low energy diet in psoriasis vulgaris treatment Coll Antropol 27 Suppl 2003 41 48
29. A.B. Kimball, C. Alavian, M. Alora-Palli, and J. Bagel Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy J Eur Acad Dermatol Venereol 26 2012 1582 1584
30. W. Roongpisuthipong, M. Pongpudpunth, C. Roongpisuthipong, and N. Rajatanavin The effect of weight loss in obese patients with chronic stable plaque-type psoriasis Dermatol Res Pract 2013 2013 795932
31. M. Del Giglio, P. Gisondi, G. Tessari, and G. Girolomoni Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study Dermatology 224 2012 31 37
32. Di Minno MN, Peluso R, Iervolino S, Russolillo A, Lupoli R, Scarpa R, et al. Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumor necrosis factor alpha blockers. Ann Rheum Dis doi: 10.1136/annrheumdis-2012-202812. Published online June 14, 2013.
33. E.W. Hossler, M.S. Maroon, and C.M. Mowad Gastric bypass surgery improves psoriasis J Am Acad Dermatol 65 2011 198 200
34. M.M. Farias, P. Achurra, C. Boza, A. Vega, and C. de la Cruz Psoriasis following bariatric surgery: clinical evolution and impact on quality of life on 10 patients Obes Surg 22 2012 877 880
35. G. Higa-Sansone, S. Szomstein, F. Soto, O. Brasecsco, C. Cohen, and R.J. Rosenthal Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity Obes Surg 14 2004 1132 1134
36. J.E. de Menezes Ettinger, E. Azaro, C.A. de Souza, P.V. dos Santos Filho, C.A. Mello, and M. Neves et al. Remission of psoriasis after open gastric bypass Obes Surg 16 2006 94 97
37. J.M. Porres Jejunoileal bypass and psoriasis Arch Dermatol 113 1977 983
38. E.W. Hossler, G.C. Wood, C.D. Still, C.M. Mowad, and M.S. Maroon The effect of weight loss surgery on the severity of psoriasis Br J Dermatol 168 2013 660 661
39. A. Faurschou, C. Zachariae, L. Skov, T. Vilsbøll, and F.K. Knop Gastric bypass surgery: improving psoriasis through a GLP-1-dependent mechanism? Med Hypotheses 77 2011 1098 1101
40. W.Q. Li, J.L. Han, M.F. Zhang, and A.A. Qureshi Interactions between adiposity and genetic polymorphisms on the risk of psoriasis Br J Dermatol 168 2013 639 642
41. G. Trynka, K.A. Hunt, N.A. Bockett, J. Romanos, V. Mistry, and A. Szperl et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease Nat Genet 43 2011 1193 1201
42. B.J. Nicklas, W. Ambrosius, S.P. Messier, G.D. Miller, B.W. Penninx, and R.F. Loeser et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial Am J Clin Nutr 79 2004 544 551